OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.17−0.18 (-13.33%)
Close on Nov 16, 2026Market cap $61.40MP/E –Yield –
OKYO Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
OKYO Pharma's enterprise value was $1.52B on May 31, 2023, against $1.37B a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2023 | May 31, 2023 | $1.52B | -18.4% |
| 2022 | Dec 30, 2022 | $1.87B | – |
See a number that looks wrong?